[1]孙建英 魏飞宇 范洁.消融指数指导下高功率短时程消融对房颤射频导管消融术后食管损伤的研究进展[J].心血管病学进展,2023,(5):434.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.012]
 SUN Jianying,WEI Feiyu,FAN Jie.High-Power Short-Duration Ablation Guided by Ablation Index for Esophageal Injury After Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2023,(5):434.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.012]
点击复制

消融指数指导下高功率短时程消融对房颤射频导管消融术后食管损伤的研究进展()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2023年5期
页码:
434
栏目:
综述
出版日期:
2023-05-25

文章信息/Info

Title:
High-Power Short-Duration Ablation Guided by Ablation Index for Esophageal Injury After Radiofrequency Ablation of Atrial Fibrillation
作者:
孙建英1 魏飞宇 12 范洁12
(1.昆明理工大学医学院,云南 昆明 650100;2.云南省第一人民医院心血管内科,云南 昆明 650100)
Author(s):
SUN Jianying 1WEI Feiyu 12FAN Jie 12
School of Medicine,Kunming University of Science and Technology,Kunming 650100,Yunnan,China; 2. Department of Cardiology,The First Peoples Hospital of Yunnan Province,Kunming 650100 ,Yunnan,China)
关键词:
心房颤动射频导管消融食管损伤消融指数高功率短时程消融
Keywords:
Atrial fibrillationRadiofrequency catheter ablationEsophageal injuryAblation indexHigh-power short-duration ablation
DOI:
10.16806/j.cnki.issn.1004-3934.2022.05.012
摘要:
射频导管消融是心力衰竭合并房颤及症状性房颤的首选治疗方案,环肺静脉隔离是房颤导管消融治疗的基石。解剖位置上食管毗邻左心房后壁,因此,左心房后壁消融时有发生食管损伤的风险,严重时会引起致命性的心房食管瘘。如何降低房颤消融术后食管损伤的发生率已成为目前临床关注的重要问题。现总结国内外关于消融指数指导下高功率短时程与低功率时程消融对房颤射频消融中食管损伤的差异,为减少房颤导管消融食管损伤提供依据。
Abstract:
Radiofrequency catheter ablation is the preferred treatment for heart failure complicated with atrial fibrillation and symptomatic atrial fibrillation. Circumferential pulmonary vein isolation is the cornerstone of catheter ablation for atrial fibrillation. Due to the anatomical location of the esophagus was adjacent to the posterior wall of the left atrium,ablation of the posterior wall of the left atrium is associated with the risk of esophageal injury and,in severe cases,developed into fatal atrioesophageal fistula . How to reduce the incidence of esophageal injury after atrial fibrillation ablation has become an important clinical concern. This review summarize d the differences between high-power short- duration ablation and low-power long- duration ablation guided by ablation index on esophageal injury in atrial fibrillation radiofrequency ablation,providing evidence for reducing the incidence of esophageal injury in atrial fibrillation radiofrequency ablation.

参考文献/References:


[1] 中华医学会心电生理和起搏分会,中国医师协会心律学专业委员会,中国房颤中心联盟心房颤动防治专家工作委员会. 心房颤动:目前的认识和治疗建议(2021)[J]. 中华心律失常学杂志, 2022,26(1):15-88.

[2] Calkins H,Kuck KH,Cappato R,et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation:recommendations for patient selection,procedural techniques,patient management and follow-up,definitions,endpoints,and research trial design[J]. Europace,2012,14(4):528-606.

[3] Barbhaiya CR,Kumar S,Guo Y,et al. Global survey of esophageal injury inatrialfibrillation ablation:characteristics and outcomes of esophageal perforation andfistula[J]. JACC Clin Electrophysiol,2016,2(2):143-150.

[4] Garg L,Garg J,Gupta N,et al. Gastrointestinal complications associated with catheter ablation for atrial fibrillation[J]. Int J Cardiol,2016,224:424-430.

[5] Kautzner J,Neuzil P,Lambert H,et al. EFFICASⅡ:optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation[J]. Europace,2015,17(8):1229-1235.

[6] Hindricks G,Potpara T,Dagres N,et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery(EACTS):the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology(ESC) developed with the special contribution of the European Heart Rhythm Association(EHRA) of the ESC[J]. Eur Heart J,2021,42(5):373-498.

[7] Contreras-Valdes FM,Heist EK,Danik SB,et al. Severity of esophageal injury predicts time to healing after radiofrequency catheter ablation for atrial fibrillation[J]. Heart Rhythm,2011,8(12):1862-1868.

[8] Halm U,Gaspar T,Zach?us M,et al. Thermal esophageal lesions after radiofrequency catheter ablation of left atrial arrhythmias[J]. Am J Gastroenterol,2010,105(3):551-556.

[9] Yarlagadda B,Deneke T,Turagam M,et al. Temporal relationships between esophageal injury type and progression in patients undergoing atrial fibrillation catheter ablation[J]. Heart Rhythm,2019,16(2):204-212.

[10] Kapur S,Barbhaiya C,Deneke T,et al. Esophageal injury and atrioesophageal fistula caused by ablation for atrial fibrillation[J]. Circulation,2017,136(13):1247-1255.

[11] Barbhaiya CR,Kumar S,John RM,et al. Global survey of esophageal and gastric injury in atrial fibrillation ablation:incidence,time to presentation,and outcomes[J]. J Am Coll Cardiol,2015,65(13):1377-1378.

[12] Li CY,Li SN,Jiang CY,et al. Atrioesophageal fistula post atrial fibrillation ablation:a multicenter study from China[J]. Pacing Clin Electrophysiol,2020,43(7):627-632.

[13] Zhang X,Kuang X,Gao X,et al. RESCUE-AF in patients undergoing atrial fibrillation ablation:the RESCUE-AF trial[J]. Circ Arrhythm Electrophysiol,2019,12(5):e007044.

[14] Zellerhoff S,Ullerich H,Lenze F,et al. Damage to the esophagus after atrial fibrillation ablation:just the tip of the iceberg? High prevalence of mediastinal changes diagnosed by endosonography[J]. Circ Arrhythm Electrophysiol,2010,3(2):155-159.

[15] Tsao HM,Wu MH,Higa S,et al. Anatomic relationship of the esophagus and left atrium:implication for catheter ablation of atrial fibrillation[J]. Chest,2005,128(4):2581-2587.

[16] Lemola K,Sneider M,Desjardins B,et al. Computed tomographic analysis of the anatomy of the left atrium and the esophagus:implications for left atrial catheter ablation[J]. Circulation,2004,110(24):3655-3660.

[17] Leite LR,Santos SN,Maia H,et al. Luminal esophageal temperature monitoring with a deflectable esophageal temperature probe and intracardiac echocardiography may reduce esophageal injury during atrial fibrillation ablation procedures:results of a pilot study[J]. Circ Arrhythm Electrophysiol,2011,4(2):149-156.

[18] Kiuchi K,Okajima K,Shimane A,et al. Impact of esophageal temperature monitoring guided atrial fibrillation ablation on preventing asymptomatic excessive transmural injury[J]. J Arrhythm,2016,32(1):36-41.

[19] Calkins H,Hindricks G,Cappato R,et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation[J]. Europace,2018,20(1):e1-e160.

[20] Marar D,Muthusamy V,Krishnan SC. Avoiding oesophageal injury during cardiac ablation:insights gained from mediastinal anatomy[J]. Europace,2018,20(3):466-471.

[21] Parikh V,Swarup V,Hantla J,et al. Feasibility,safety,and efficacy of a novel preshaped nitinol esophageal deviator to successfully deflect the esophagus and ablate left atrium without esophageal temperature rise during atrial fibrillation ablation:the DEFLECT GUT study[J]. Heart Rhythm,2018,15(9):1321-1327.

[22] Martinek M,Bencsik G,Aichinger J,et al. Esophageal damage during radiofrequency ablation of atrial fibrillation:impact of energy settings,lesion sets,and esophageal visualization[J]. J Cardiovasc Electrophysiol,2009,20(7):726-733.

[23] di Biase L,Saenz LC,Burkhardt DJ,et al. Esophageal capsule endoscopy after radiofrequency catheter ablation for atrial fibrillation:documented higher risk of luminal esophageal damage with general anesthesia as compared with conscious sedation[J]. Circ Arrhythm Electrophysiol,2009,2(2):108-112.

[24] Calkins H,Hindricks G,Cappato R,et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation[J]. Heart Rhythm,2017,14(10):e275-e444.

[25] Castrejón-Castrejón S,Martínez Cossiani M,Ortega Molina M,et al. Feasibility and safety of pulmonary vein isolation by high-power short-duration radiofrequency application:short-term results of the POWER-FAST PILOT study[J]. J Interv Card Electrophysiol,2020,57(1):57-65.

[26] Chen S,Schmidt B,Seeger A,et al. Catheter ablation of atrial fibrillation using ablation index-guided high power(50 W) for pulmonary vein isolation with or without esophageal temperature probe(the AI-HP ESO Ⅱ)[J]. Heart Rhythm,2020,17(11):1833-1840.

[27] Barkagan M,Contreras-Valdes FM,Leshem E,et al. High-power and short-duration ablation for pulmonary vein isolation:Safety,efficacy,and long-term durability[J]. J Cardiovasc Electrophysiol,2018,29(9):1287-1296.

[28] Vassallo F,Meigre LL,Serpa E,et al. Reduced esophageal heating in high-power short-duration atrial fibrillation ablation in the contact force catheter era[J]. Pacing Clin Electrophysiol,2021,44(7):1185-1192.

[29] Do U,Kim J,Kim M,et al. Esophageal thermal injury after catheter ablation for atrial fibrillation with high-power(50 Watts) radiofrequency energy[J]. Korean Circ J,2021,51(2):143-153.

[30] Winkle RA,Mohanty S,Patrawala RA,et al. Low complication rates using high power(45-50 W) for short duration for atrial fibrillation ablations[J]. Heart Rhythm,2019,16(2):165-169.

[31] Park JW,Yang SY,Kim M,et al. Efficacy and safety of high-power short-duration radiofrequency catheter ablation of atrial fibrillation[J]. Front Cardiovasc Med,2021,8:709585.

[32] Chen CF,Wu J,Jin CL,et al. Comparison of high-power short-duration and low-power long-duration radiofrequency ablation for treating atrial fibrillation:systematic review and meta-analysis[J]. Clin Cardiol,2020,43(12):1631-1640.

[33] Das M,Loveday JJ,Wynn GJ,et al. Ablation index,a novel marker of ablation lesion quality:prediction of pulmonary vein reconnection at repeat electrophysiology study and regional differences in target values[J]. Europace,2017,19(5):775-783.

[34] Casella M,Dello Russo A,Riva S,et al. An ablation index operator-independent approach to improve efficacy in atrial fibrillation ablation at 24-month follow-up:a single center experience[J]. J Interv Card Electrophysiol,2020,57(2):241-249.

[35] Kiliszek M,Krzy?anowski K,Wierzbowski R,et al. The value of the ablation index in patients undergoing ablation for atrial fibrillation[J]. Kardiol Pol,2020,78(10):1015-1019.

[36] Lozano Granero C,Franco E,Matía Francés R,et al. Impact of power and contact force on index-guided radiofrequency lesions in an ex vivo porcine heart model[J]. J Interv Card Electrophysiol,2022,63(3):687-697.

[37] Whitaker J,Fish J,Harrison J,et al. Lesion index-guided ablation facilitates continuous,transmural,and durable lesions in a porcine recovery model[J]. Circ Arrhythm Electrophysiol,2018,11(4):e005892.

[38] Müller J,Berkovitz A,Halbfass P,et al. Acute oesophageal safety of high-power short duration with 50 W for atrial fibrillation ablation[J]. Europace,2022,24(6):928-937.

[39] Chen S,Schmidt B,Bordignon S,et al. Ablation index-guided 50W ablation for pulmonary vein isolation in patients with atrial fibrillation:procedural data,lesion analysis,and initial results from the FAFA AI High Power Study[J]. J Cardiovasc Electrophysiol,2019,30(12):2724-2731.

[40] Kaneshiro T,Kamioka M,Hijioka N,et al. Characteristics of esophageal injury in ablation of atrial fibrillation using a high-power short-duration setting[J]. Circ Arrhythm Electrophysiol,2020,13(10):e008602.

[41] Yavin HD,Bubar ZP,Higuchi K,et al. Impact of high-power short-duration radiofrequency ablation on esophageal temperature dynamic[J]. Circ Arrhythm Electrophysiol,2021,14(11):e010205.

[42] Liu Z,Liu LF,Liu XQ,et al. Ablation index-guided ablation with milder targets for atrial fibrillation:comparison between high power and low power ablation[J]. Front Cardiovasc Med,2022,9:949918.

[43] 苗旺,张楠,郭敏,等. 消融指数指导下高功率消融在老年心房颤动患者中的应用效果[J]. 中华老年心脑血管病杂志,2022 ,24(2):151-154.

[44] Chen S,Schmidt B,Bordignon S,et al. Catheter ablation of atrial fibrillation using ablation index-guided high-power technique:Frankfurt AI high-power 15-month?follow-up[J]. J Cardiovasc Electrophysiol,2021,32(3):616-624.

[45] Wielandts JY,Kyriakopoulou M,Almorad A,et al. Prospective randomized evaluation of high power during CLOSE-guided pulmonary vein isolation:the POWER-AF study[J]. Circ Arrhythm Electrophysiol,2021,14(1):e009112.

相似文献/References:

[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
 HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(5):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
 DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(5):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
 ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
 ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
 HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
 WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
 XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(5):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
 ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
 WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
 ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
[11]于春鑫 孙姣 孙源君 尹晓盟.心房颤动导管消融相关心房食管瘘的研究进展[J].心血管病学进展,2020,(7):691.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.005]
 YU Chunxin,SUN Jiao,SUN Yuanjun,et al.Atrioesophageal Fistula Associated with Catheter Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2020,(5):691.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.005]

备注/Memo

备注/Memo:
收稿日期:2022-09-07
更新日期/Last Update: 2023-06-29